Certuity LLC purchased a new stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 6,400 shares of the company’s stock, valued at approximately $258,000. Several other hedge funds have also added […]

Related Keywords

Wellington , New Zealand General , New Zealand , Bio Pharma , Randalw Scott , , Northern Trust Corp , Primecap Management Co , Cantor Fitzgerald , Charles Schwab Investment Management Inc , Citigroup , Securities Exchange Commission , Bio Pharma Inc , Nasdaq , Exchange Commission , Wellington Management Group , Bridgebio Pharma Inc , Lord Abbett , Bridgebio Pharma , Free Report , Management Group , Trust Corp , Schwab Investment Management , Get Free Report , Director Randal , Bridgebio Pharma Daily ,